Literature DB >> 11941477

Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly.

Jeffrey E Ming1, Michelle E Kaupas, Erich Roessler, Han G Brunner, Mahin Golabi, Mustafa Tekin, Robert F Stratton, Eva Sujansky, Sherri J Bale, Maximilian Muenke.   

Abstract

Holoprosencephaly (HPE) is the most commonly occurring congenital structural forebrain anomaly in humans. HPE is associated with mental retardation and craniofacial malformations. The genetic causes of HPE have recently begun to be identified, and we have previously shown that HPE can be caused by haploinsufficiency for SONIC HEDGEHOG ( SHH). We hypothesize that mutations in genes encoding other components of the SHH signaling pathway could also be associated with HPE. PATCHED-1 (PTCH), the receptor for SHH, normally acts to repress SHH signaling. This repression is relieved when SHH binds to PTCH. We analyzed PTCH as a candidate gene for HPE. Four different mutations in PTCHwere detected in five unrelated affected individuals. We predict that by enhancing the repressive activity of PTCH on the SHH pathway, these mutations cause decreased SHH signaling, and HPE results. The mutations could affect the ability of PTCH to bind SHH or perturb the intracellular interactions of PTCH with other proteins involved in SHH signaling. These findings further demonstrate the genetic heterogeneity associated with HPE, as well as showing that mutations in different components of a single signaling pathway can result in the same clinical condition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941477     DOI: 10.1007/s00439-002-0695-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  71 in total

1.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

Review 2.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

Review 3.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

4.  Schilbach-Rott syndrome associated with 9q22.32q22.33 duplication, involving the PTCH1 gene.

Authors:  Paolo Prontera; Daniela Rogaia; Ester Sallicandro; Amedea Mencarelli; Valentina Imperatore; Gabriella Maria Squeo; Giuseppe Merla; Sandro Elisei; Danilo Moretti-Ferreira; Susanna Esposito; Gabriela Stangoni
Journal:  Eur J Hum Genet       Date:  2019-04-01       Impact factor: 4.246

5.  Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.

Authors:  Erich Roessler; Jorge I Vélez; Nan Zhou; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-01-12       Impact factor: 4.797

6.  Mechanism and ultrasensitivity in Hedgehog signaling revealed by Patched1 disease mutations.

Authors:  Kostadin Petrov; Taciani de Almeida Magalhaes; Adrian Salic
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

7.  The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis.

Authors:  Erich Roessler; Kenia B El-Jaick; Christèle Dubourg; Jorge I Vélez; Benjamin D Solomon; Daniel E Pineda-Alvarez; Felicitas Lacbawan; Nan Zhou; Maia Ouspenskaia; Aimée Paulussen; Hubert J Smeets; Ute Hehr; Claude Bendavid; Sherri Bale; Sylvie Odent; Véronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

8.  Truncating loss-of-function mutations of DISP1 contribute to holoprosencephaly-like microform features in humans.

Authors:  Erich Roessler; Yong Ma; Maia V Ouspenskaia; Felicitas Lacbawan; Claude Bendavid; Christèle Dubourg; Philip A Beachy; Maximilian Muenke
Journal:  Hum Genet       Date:  2009-01-31       Impact factor: 4.132

Review 9.  Controlling destiny through chemistry: small-molecule regulators of cell fate.

Authors:  Ari J Firestone; James K Chen
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

10.  Cleft lip and palate genetics and application in early embryological development.

Authors:  Wenli Yu; Maria Serrano; Symone San Miguel; L Bruno Ruest; Kathy K H Svoboda
Journal:  Indian J Plast Surg       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.